Last reviewed · How we verify
NCT03700008
Content-free Speech Analysis for Measurement of Mental Health
NA trial testing Speech analysis tool in Mental Disorder in 210 participants. Completed in 30 December 2020.
31 October 2020
Quick facts
| Lead sponsor | Neuropsychiatrischen Zentrums Hamburg-Altona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 210 |
| Start date | 15 October 2018 |
| Primary completion | 31 October 2020 |
| Estimated completion | 30 December 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Speech analysis tool
- Conventional psychological measurements
Conditions studied
- Mental Disorder — all drugs for Mental Disorder →
- Conditions Influencing Health Status — all drugs for Conditions Influencing Health Status →
Sponsor
Neuropsychiatrischen Zentrums Hamburg-Altona
Who can join
Adults 18 to 65, any sex, with Mental Disorder or Conditions Influencing Health Status. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Trial to prove the functionality and efficacy of a content-free speech analysis tool to detect problematic mental health status or phases of patients with pre known or unknown mental health disorders, focussed on affective disorders or neurodevelopmental disorders. The participants talk in free speech to the tool, this will be analyzed content-free and compared with psychological instruments to detect the mental status in conventional way.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Digital Content-Free Speech Analysis Tool to Measure Affective Distress in Mental Health: Evaluation Study.
Tonn P, Seule L, Degani Y, Herzinger S, et al · · 2022 · cited 3× · PMID 36040767 · DOI 10.2196/37061 -
Development of a Digital Content-Free Speech Analysis Tool for the Measurement of Mental Health and Follow-Up for Mental Disorders: Protocol for a Case-Control Study.
Tonn P, Degani Y, Hershko S, Klein A, et al · · 2020 · cited 3× · PMID 32406862 · DOI 10.2196/13852
Verify or expand the search:
- PubMed search for NCT03700008
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mental Disorder
Currently open trials in the same condition.
- NCT07010614 — Brain Stimulation to the Hippocampus in Schizophrenia · NA · recruiting
- NCT06929533 — Pharmacogenomics-Supported Psychotropic Prescribing Trial · NA · recruiting
- NCT06813066 — Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence · NA · active not recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
- NCT06625437 — ACT for HIV-Positive Men · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03700008 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuropsychiatrischen Zentrums Hamburg-Altona
- Last refreshed: 20 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03700008.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing